BenevolentAI

What is BenevolentAI?

BenevolentAI (Euronext Amsterdam: BAI) is a company that applies advanced AI to accelerate biopharma drug discovery. Their next-generation platform targets the complex decisions that drive R&D, providing life science intelligence. They build technology in the service of science, bringing together science and technology teams to push AI and machine learning to new limits. They leverage their knowledge graph and proprietary ontologies to support scientists and executives in leveraging cutting-edge AI with confidence and precision.

How to use BenevolentAI?

The website provides information about BenevolentAI’s platform and its applications in drug discovery. Users can explore the company’s philosophy, contact them for more information, and access resources like regulatory archives, terms and conditions, privacy policy, cookie declaration, accessibility information, and a sitemap.

BenevolentAI’s Core Features

AI-driven drug discovery platform Knowledge graph and proprietary ontologies Life science intelligence

BenevolentAI’s Use Cases

• Accelerating the identification of potential drug candidates
• Improving the efficiency of drug development processes
• Providing insights into complex biological systems